Michael Barbella, Managing Editor04.10.24
KARL STORZ is centralizing the management of its U.S. organizations, including its research and development, manufacturing, and commercial operations, to bring more products to market quicker. Sonal Matai, who has led the U.S. commercial business for two years, has been appointed president of KARL STORZ in the United States.
“Our new organizational structure will bring benefits to all our stakeholders. Our suppliers and vendor partners will benefit from streamlined interactions with an integrated KARL STORZ in the U.S.,” Matai said.
Matai was previously managing director, KARL STORZ Endoscopy-America Inc. His prior leadership experiences at large medtech companies and startups, as well as his global outlook and dedication to innovation and customer satisfaction, have honed his ability to drive progress and steer market leadership.
“The U.S. is the world’s largest medical device market and also the largest market for KARL STORZ,” Matai stated. “Our 2,700 employees in the United States can now work together more closely to create an enhanced customer experience in this critical geography through innovative products and service.”
KARL STORZ United States develops endoscopic technology and imaging solutions across virtually all surgical specialties. It is a subsidiary of KARL STORZ SE & Co. KG, an international medical technology company that is family-owned and based in Tuttlingen, Germany. KARL STORZ has a portfolio that includes more than 15,000 products for human and veterinary medicine.
“Our new organizational structure will bring benefits to all our stakeholders. Our suppliers and vendor partners will benefit from streamlined interactions with an integrated KARL STORZ in the U.S.,” Matai said.
Matai was previously managing director, KARL STORZ Endoscopy-America Inc. His prior leadership experiences at large medtech companies and startups, as well as his global outlook and dedication to innovation and customer satisfaction, have honed his ability to drive progress and steer market leadership.
“The U.S. is the world’s largest medical device market and also the largest market for KARL STORZ,” Matai stated. “Our 2,700 employees in the United States can now work together more closely to create an enhanced customer experience in this critical geography through innovative products and service.”
KARL STORZ United States develops endoscopic technology and imaging solutions across virtually all surgical specialties. It is a subsidiary of KARL STORZ SE & Co. KG, an international medical technology company that is family-owned and based in Tuttlingen, Germany. KARL STORZ has a portfolio that includes more than 15,000 products for human and veterinary medicine.